10.3389/fimmu.2018.00324.s012
Cheleka A. M. Mpande
Cheleka A. M.
Mpande
One B. Dintwe
One B.
Dintwe
Munyaradzi Musvosvi
Munyaradzi
Musvosvi
Simbarashe Mabwe
Simbarashe
Mabwe
Nicole Bilek
Nicole
Bilek
Mark Hatherill
Mark
Hatherill
Elisa Nemes
Elisa
Nemes
Thomas J. Scriba
Thomas
J. Scriba
The SATVI Clinical Immunology Team
The SATVI Clinical Immunology
Team
Table_1.PDF
Frontiers
2018
TSCM
Mycobacterium tuberculosis
memory T cells
QuantiFERON conversion
LTBI
2018-03-01 10:38:25
Dataset
https://frontiersin.figshare.com/articles/dataset/Table_1_PDF/5938270
Background<p>Maintenance of long-lasting immunity is thought to depend on stem cell memory T cells (T<sub>SCM</sub>), which have superior self-renewing capacity, longevity and proliferative potential compared with central memory (T<sub>CM</sub>) or effector (T<sub>EFF</sub>) T cells. Our knowledge of T<sub>SCM</sub> derives primarily from studies of virus-specific CD8<sup>+</sup> T<sub>SCM</sub>. We aimed to determine if infection with Mycobacterium tuberculosis (M. tb), the etiological agent of tuberculosis, generates antigen-specific CD4<sup>+</sup> T<sub>SCM</sub> and to characterize their functional ontology.</p>Methods<p>We studied T cell responses to natural M. tb infection in a longitudinal adolescent cohort of recent QuantiFERON-TB Gold (QFT) converters and three cross-sectional QFT<sup>+</sup> adult cohorts; and to bacillus Calmette–Guerin (BCG) vaccination in infants. M. tb and/or BCG-specific CD4 T cells were detected by flow cytometry using major histocompatibility complex class II tetramers bearing Ag85, CFP-10, or ESAT-6 peptides, or by intracellular cytokine staining. Transcriptomic analyses of M. tb-specific tetramer<sup>+</sup> CD4<sup>+</sup> T<sub>SCM</sub> (CD45RA<sup>+</sup> CCR7<sup>+</sup> CD27<sup>+</sup>) were performed by microfluidic qRT-PCR, and functional and phenotypic characteristics were confirmed by measuring expression of chemokine receptors, cytotoxic molecules and cytokines using flow cytometry.</p>Results<p>M. tb-specific T<sub>SCM</sub> were not detected in QFT-negative persons. After QFT conversion frequencies of T<sub>SCM</sub> increased to measurable levels and remained detectable thereafter, suggesting that primary M. tb infection induces T<sub>SCM</sub> cells. Gene expression (GE) profiling of tetramer<sup>+</sup> T<sub>SCM</sub> showed that these cells were distinct from bulk CD4<sup>+</sup> naïve T cells (T<sub>N</sub>) and shared features of bulk T<sub>SCM</sub> and M. tb-specific tetramer<sup>+</sup> T<sub>CM</sub> and T<sub>EFF</sub> cells. These T<sub>SCM</sub> were predominantly CD95<sup>+</sup> and CXCR3<sup>+</sup>, markers typical of CD8<sup>+</sup> T<sub>SCM</sub>. Tetramer<sup>+</sup> T<sub>SCM</sub> expressed significantly higher protein levels of CCR5, CCR6, CXCR3, granzyme A, granzyme K, and granulysin than bulk T<sub>N</sub> and T<sub>SCM</sub> cells. M. tb-specific T<sub>SCM</sub> were also functional, producing IL-2, IFN-γ, and TNF-α upon antigen stimulation, and their frequencies correlated positively with long-term BCG-specific CD4<sup>+</sup> T cell proliferative potential after infant vaccination.</p>Conclusion<p>Human infection with M. tb induced distinct, antigen-specific CD4<sup>+</sup> T<sub>SCM</sub> cells endowed with effector functions, including expression of cytotoxic molecules and Th1 cytokines, and displayed chemokine receptor profiles consistent with memory Th1/17 cells. Induction of CD4<sup>+</sup> T<sub>SCM</sub> should be considered for vaccination approaches that aim to generate long-lived memory T cells against M. tb.</p>